Glucagon-like polypeptide-1 and brain

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Glucagon-like polypeptide-1 has specific effects on the central nervous system, including regulation of glucose metabolism, positive cardiovascular effects, slowing intestinal motility, immune modulation, and regulation of appetite and energy expenditure. Recently, positive effects of GLP-1 on brain energy utilization, inhibition and restoration of neurodegeneration, response to stress, and protection against ischemic neuron damage have been demonstrated. Herein, the effects of glucagon-like polypeptide-1 on the central nervous system will be discussed.

References Powered by Scopus

Liraglutide and cardiovascular outcomes in type 2 diabetes

5495Citations
N/AReaders
Get full text

Semaglutide and cardiovascular outcomes in patients with type 2 diabetes

4406Citations
N/AReaders
Get full text

Pharmacology, physiology, and mechanisms of incretin hormone action

1149Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Diabetes mellitus associated neurovascular lesions in the retina and brain: A review

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bakiner, O. S., & Özşahin, A. K. (2020). Glucagon-like polypeptide-1 and brain. Turkish Journal of Endocrinology and Metabolism, 24(4), 343–355. https://doi.org/10.25179/tjem.2020-77362

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

40%

Researcher 2

40%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

75%

Nursing and Health Professions 1

25%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 65

Save time finding and organizing research with Mendeley

Sign up for free